Parameter Set Neuroleptics 1/EXTENDED - LC-MS/MS
Encompasses 11 analytes
3PLUS1® Multilevel Calibrator Set available
Part of the MassTox® TDM Series A
CE-IVD validated product ready for IVDR within timeframes and transition periods specified by the IVDR 2017/746
![](https://stage.c-477.maxcluster.net/media/images/chromatograms-kits/92912-XT_EN_Neuroleptics-1.jpg)
![](https://stage.c-477.maxcluster.net/media/images/chromatograms-kits/92912-XT_EN_Neuroleptics-1.jpg)
Aripiprazole
Dehydroaripiprazole
Clozapine
N-Desmethylclozapine
Haloperidol
Olanzapine
N-Desmethylolanzapine
Quetiapine
Norquetiapine
Risperidone
9-OH-Risperidone
Clinical relevance
Neuroleptic agents, also known as antipsychotics, are used to treat psychosis and other psychological disorders such as severe manic depressive conditions accompanied by delusions and hallucinations. Their effect is based on influencing the synaptic conduction in the central nervous system. The neuroleptics bind to specific receptors of the neurotransmitters such as dopamine, preventing transmission of stimulus information and leading to inhibition of the transmission of neural signals.
To avoid interferences and to enable an accurate analysis, the neuroleptics are divided into two Parameter Sets, Neuroleptics 1/EXTENDED and Neuroleptics 2/EXTENDED 2. The present analysis set Neuroleptics 1/EXTENDED has been extended by the metabolites norquetiapine and dehydroaripiprazole.
Product advantages
With the Parameter Set Neuroleptics 1/EXTENDED in serum/plasma, 11 different analytes can be measured fast and efficiently using LC-MS/MS. Due to the careful optimisation of all kit components as well as the chromatographic separation, matrix effects (“ion suppression”) are minimised and the robustness of the method is enhanced. Sample preparation is based on a protein precipitation step. The use of stable isotopically labelled (deuterated) and co-eluting internal standards as well as 3PLUS1® multilevel calibrators ensures high precision and reproducible and reliable quantification of the analytes. The method is comprehensively validated.
The Parameter Set is a part of the Series A modular system, which enables the analysis of all parameters without switching column or changing the mobile phases, thereby minimising required workload in the laboratory. The Basic Kit A contains all components required for sample preparation and all necessary mobile phases. The MasterColumn® A is the analytical column used for the determination of all Series A analytes. Our portfolio contains further MassTox® Parameter Sets.
For the analysis you require the MassTox® TDM Basic Kit A, the specific MassTox® TDM Parameter Set and the analytical column MassTox® TDM MasterColumn® A.
Method of Analysis | LC-MS/MS |
---|---|
Please note | The freely available information on this website, in particular on the sample preparation, are not sufficient to work with our products. Please read instructions and warning notices on products and/or instruction manuals. |
Lower Limit of Quantitation | 0.5 – 35 μg/l |
Upper Limit of Quantification | at least twice the therapeutic range |
Intraassay | CV < 7 % |
Interassay | CV < 8 % |
Specimen | Serum/Plasma |
Sample Preparation |
|
Run Time | 3 min |
Injection Volume | 0.2 – 50 µl |
Gradient | 0.00 - 0.20 min 20 % Mobile Phase 2 |
Ionisation | ESI positive |
MS/MS Mode | MRM |
Additional Info | We recommend to set the scan time to a value that allows to achieve a minimum of 10 data points over the whole peak width. |
Parameters | 9-OH-Risperidone, Aripiprazole, Clozapine, Dehydroaripiprazole, Haloperidol, N-Desmethylclozapine, N-Desmethylolanzapine, Norquetiapine, Olanzapine, Quetiapine, Risperidone |
-
Internal Standard Set Antidepressants 1/EXTENDED and Neuroleptics 1/EXTENDEDOrder no.: 92046/AN1/XT
Component of the Parameter Sets Antidepressants 1/EXTENDED and Neuroleptics 1/EXTENDED, available separately
-
3PLUS1® Multilevel Plasma Calibrator Set Neuroleptics 1/ EXTENDEDOrder no.: 92028/XTMassTox® TDM Series A Neuroleptics 1/EXTENDED in Serum/Plasma – LC-MS/MS
-
MassCheck® Neuroleptics 1/EXTENDED Plasma ControlsOrder no.: 0210/XT; 0211/XT; 0212/XTMassTox® TDM Series A Neuroleptics 1/EXTENDED in Serum/Plasma – LC-MS/MS
-
MassTox® TDM MasterColumn® AOrder no.: 92110
Analytical column for MassTox® TDM Series A - LC-MS/MS
-
Tuning Mix Neuroleptics 1/EXTENDEDOrder no.: 92015/N1/XTTuning Mix for the Parameter Set Neuroleptics 1/EXTENDED - LC-MS/MS
-
Basic Kit A for 200 Tests - LC-MS/MSOrder no.: 92111/200
Part of the MassTox® TDM Series A
Modular system for therapeutic drug monitoring
Provides all components required for sample prep and all mobile phasesCE-IVD validated product ready for IVDR within timeframes and transition periods specified by the IVDR 2017/746
-
Basic Kit A for 1000 Tests - LC-MS/MSOrder no.: 92111/1000
Part of the MassTox® TDM Series A
Modular system for therapeutic drug monitoring
Provides all components required for sample prep and all mobile phasesCE-IVD validated product ready for IVDR within timeframes and transition periods specified by the IVDR 2017/746
-
3PLUS1® Multilevel Plasma Calibrator Set Neuroleptics 1/ EXTENDEDOrder no.: 92028/XTMassTox® TDM Series A Neuroleptics 1/EXTENDED in Serum/Plasma – LC-MS/MS
-
MassCheck® Neuroleptics 1/EXTENDED Plasma ControlsOrder no.: 0210/XT; 0211/XT; 0212/XTMassTox® TDM Series A Neuroleptics 1/EXTENDED in Serum/Plasma – LC-MS/MS
![](https://stage.c-477.maxcluster.net/media/images/chromatograms-kits/92912-XT_EN_Neuroleptics-1.jpg)
![](https://stage.c-477.maxcluster.net/media/images/chromatograms-kits/92912-XT_EN_Neuroleptics-1.jpg)
Aripiprazole
Dehydroaripiprazole
Clozapine
N-Desmethylclozapine
Haloperidol
Olanzapine
N-Desmethylolanzapine
Quetiapine
Norquetiapine
Risperidone
9-OH-Risperidone
Clinical relevance
Neuroleptic agents, also known as antipsychotics, are used to treat psychosis and other psychological disorders such as severe manic depressive conditions accompanied by delusions and hallucinations. Their effect is based on influencing the synaptic conduction in the central nervous system. The neuroleptics bind to specific receptors of the neurotransmitters such as dopamine, preventing transmission of stimulus information and leading to inhibition of the transmission of neural signals.
To avoid interferences and to enable an accurate analysis, the neuroleptics are divided into two Parameter Sets, Neuroleptics 1/EXTENDED and Neuroleptics 2/EXTENDED 2. The present analysis set Neuroleptics 1/EXTENDED has been extended by the metabolites norquetiapine and dehydroaripiprazole.
Product advantages
With the Parameter Set Neuroleptics 1/EXTENDED in serum/plasma, 11 different analytes can be measured fast and efficiently using LC-MS/MS. Due to the careful optimisation of all kit components as well as the chromatographic separation, matrix effects (“ion suppression”) are minimised and the robustness of the method is enhanced. Sample preparation is based on a protein precipitation step. The use of stable isotopically labelled (deuterated) and co-eluting internal standards as well as 3PLUS1® multilevel calibrators ensures high precision and reproducible and reliable quantification of the analytes. The method is comprehensively validated.
The Parameter Set is a part of the Series A modular system, which enables the analysis of all parameters without switching column or changing the mobile phases, thereby minimising required workload in the laboratory. The Basic Kit A contains all components required for sample preparation and all necessary mobile phases. The MasterColumn® A is the analytical column used for the determination of all Series A analytes. Our portfolio contains further MassTox® Parameter Sets.
For the analysis you require the MassTox® TDM Basic Kit A, the specific MassTox® TDM Parameter Set and the analytical column MassTox® TDM MasterColumn® A.
Method of Analysis | LC-MS/MS |
---|---|
Please note | The freely available information on this website, in particular on the sample preparation, are not sufficient to work with our products. Please read instructions and warning notices on products and/or instruction manuals. |
Lower Limit of Quantitation | 0.5 – 35 μg/l |
Upper Limit of Quantification | at least twice the therapeutic range |
Intraassay | CV < 7 % |
Interassay | CV < 8 % |
Specimen | Serum/Plasma |
Sample Preparation |
|
Run Time | 3 min |
Injection Volume | 0.2 – 50 µl |
Gradient | 0.00 - 0.20 min 20 % Mobile Phase 2 |
Ionisation | ESI positive |
MS/MS Mode | MRM |
Additional Info | We recommend to set the scan time to a value that allows to achieve a minimum of 10 data points over the whole peak width. |
Parameters | 9-OH-Risperidone, Aripiprazole, Clozapine, Dehydroaripiprazole, Haloperidol, N-Desmethylclozapine, N-Desmethylolanzapine, Norquetiapine, Olanzapine, Quetiapine, Risperidone |
-
Internal Standard Set Antidepressants 1/EXTENDED and Neuroleptics 1/EXTENDEDOrder no.: 92046/AN1/XT
Component of the Parameter Sets Antidepressants 1/EXTENDED and Neuroleptics 1/EXTENDED, available separately
-
3PLUS1® Multilevel Plasma Calibrator Set Neuroleptics 1/ EXTENDEDOrder no.: 92028/XTMassTox® TDM Series A Neuroleptics 1/EXTENDED in Serum/Plasma – LC-MS/MS
-
MassCheck® Neuroleptics 1/EXTENDED Plasma ControlsOrder no.: 0210/XT; 0211/XT; 0212/XTMassTox® TDM Series A Neuroleptics 1/EXTENDED in Serum/Plasma – LC-MS/MS
-
MassTox® TDM MasterColumn® AOrder no.: 92110
Analytical column for MassTox® TDM Series A - LC-MS/MS
-
Tuning Mix Neuroleptics 1/EXTENDEDOrder no.: 92015/N1/XTTuning Mix for the Parameter Set Neuroleptics 1/EXTENDED - LC-MS/MS
-
Basic Kit A for 200 Tests - LC-MS/MSOrder no.: 92111/200
Part of the MassTox® TDM Series A
Modular system for therapeutic drug monitoring
Provides all components required for sample prep and all mobile phasesCE-IVD validated product ready for IVDR within timeframes and transition periods specified by the IVDR 2017/746
-
Basic Kit A for 1000 Tests - LC-MS/MSOrder no.: 92111/1000
Part of the MassTox® TDM Series A
Modular system for therapeutic drug monitoring
Provides all components required for sample prep and all mobile phasesCE-IVD validated product ready for IVDR within timeframes and transition periods specified by the IVDR 2017/746
-
3PLUS1® Multilevel Plasma Calibrator Set Neuroleptics 1/ EXTENDEDOrder no.: 92028/XTMassTox® TDM Series A Neuroleptics 1/EXTENDED in Serum/Plasma – LC-MS/MS
-
MassCheck® Neuroleptics 1/EXTENDED Plasma ControlsOrder no.: 0210/XT; 0211/XT; 0212/XTMassTox® TDM Series A Neuroleptics 1/EXTENDED in Serum/Plasma – LC-MS/MS